Anti-PATT1抗体
Anti-PATT1 antibody
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Polyclonal PATT1 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human NAA40.
查看别名
NAT11, PATT1, NAA40, N-alpha-acetyltransferase 40, N-acetyltransferase 11, N-alpha-acetyltransferase D, Protein acetyltransferase 1, NatD, hNatD
- WB
Unknown
Western blot - Anti-PATT1 antibody (AB106408)
Lane 1:
Western blot - Anti-PATT1 antibody (ab106408) at 1 µg/mL
Lane 2:
Western blot - Anti-PATT1 antibody (ab106408) at 2 µg/mL
All lanes:
Human thymus tissue lysate at 15 µg
Predicted band size: 27 kDa
false
- ICC/IF
CiteAb
Immunocytochemistry/ Immunofluorescence - Anti-PATT1 antibody (AB106408)
Western Blotting using Anti-PATT1 antibody, ab106408. Publication image from Ju, J. et al., 2017, Nat Commun, 29030587. Legend direct from paper.
Regulation of Slug by NatD is acetyltransferase activity-dependent. a (left) In vitro acetylation assay showing the catalytic activity of NatDδ and wild-type NatD (CPM, counts per minute). Data are mean ± s.d. of three independent experiments; Student’s t-test, **P < 0.01 compared with wild-type NatD. (right) SDS-PAGE analysis of purified recombinant NatDδ and wild-type NatD proteins from E. coli stained by Coomassie brilliant blue (CBB). MW, protein molecular weight markers. b (top) Western blot analysis of an H4 (1–31) peptide from in vitro acetylation assay in the presence of NatDδ or wild-type NatD. (bottom) H4 (1–31) peptide shown by Coomassie blue staining. Blots are representative of three independent experiments. c (top) Autoradiographic image showing products from in vitro acetylation assay using histones as substrates extracted from H1299 cells. Results are representative of three independent experiments. (bottom) Histones shown by Coomassie blue staining. d Quantitative real-time PCR analysis of mRNA levels of Slug, E-cadherin, N-cadherin, and Vimentin normalized to GAPDH in H1299 cells overexpressing NatDδ or wild-type NatD. Data are mean ± s.d. of three independent experiments; Student’s t-test, **P < 0.01 compared with the wild-type NatD. e Western blot analysis of indicated proteins from H1299 cells overexpressing NatDδ or wild-type NatD. GAPDH and histone H4 served as loading controls. Data are representative of three independent experiments. f, g Representative images of the migration (e) and invasion (f) of H1299 cells overexpressing NatDδ or wild-type NatD with transwell assay from three independent experiments (top panel). Cell counts for the corresponding assays of at least four random microscope fields (x100 magnification). Cell migration and invasion are expressed as a percentage of control (bottom panel). Results are shown as mean ± s.d. from three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared with the indicated control
- WB
CiteAb
Western blot - Anti-PATT1 antibody (AB106408)
Western Blotting using Anti-PATT1 antibody, ab106408. Publication image from Ju, J. et al., 2017, Nat Commun, 29030587. Legend direct from paper.
Regulation of Slug by NatD is acetyltransferase activity-dependent. a (left) In vitro acetylation assay showing the catalytic activity of NatDδ and wild-type NatD (CPM, counts per minute). Data are mean ± s.d. of three independent experiments; Student’s t-test, **P < 0.01 compared with wild-type NatD. (right) SDS-PAGE analysis of purified recombinant NatDδ and wild-type NatD proteins from E. coli stained by Coomassie brilliant blue (CBB). MW, protein molecular weight markers. b (top) Western blot analysis of an H4 (1–31) peptide from in vitro acetylation assay in the presence of NatDδ or wild-type NatD. (bottom) H4 (1–31) peptide shown by Coomassie blue staining. Blots are representative of three independent experiments. c (top) Autoradiographic image showing products from in vitro acetylation assay using histones as substrates extracted from H1299 cells. Results are representative of three independent experiments. (bottom) Histones shown by Coomassie blue staining. d Quantitative real-time PCR analysis of mRNA levels of Slug, E-cadherin, N-cadherin, and Vimentin normalized to GAPDH in H1299 cells overexpressing NatDδ or wild-type NatD. Data are mean ± s.d. of three independent experiments; Student’s t-test, **P < 0.01 compared with the wild-type NatD. e Western blot analysis of indicated proteins from H1299 cells overexpressing NatDδ or wild-type NatD. GAPDH and histone H4 served as loading controls. Data are representative of three independent experiments. f, g Representative images of the migration (e) and invasion (f) of H1299 cells overexpressing NatDδ or wild-type NatD with transwell assay from three independent experiments (top panel). Cell counts for the corresponding assays of at least four random microscope fields (x100 magnification). Cell migration and invasion are expressed as a percentage of control (bottom panel). Results are shown as mean ± s.d. from three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared with the indicated control
false
- WB
CiteAb
Western blot - Anti-PATT1 antibody (AB106408)
Western Blotting using Anti-PATT1 antibody, ab106408. Publication image from Ju, J. et al., 2017, Nat Commun, 29030587. Legend direct from paper.
NatD is required for lung cancer cell migration and invasion in vitro. a Quantitative real-time PCR analysis of NatD mRNA levels normalized to GAPDH in scrambled control cells (Scr) and NatD-KD1 and NatD-KD2 cells. Results are shown as mean ± s.d. from three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared to Scr control. b Western blot analysis of NatD and Nt-ac-H4 protein levels in scrambled, NatD-KD1, and NatD-KD2 cells. GAPDH and histone H4 served as loading controls. Blots are representative of three independent experiments. c Representative images from wound healing assay of scrambled, NatD-KD1, and NatD-KD2 cells from three independent experiments (left panels). Wound healing assay results are quantified in the histogram (right panel). Results are shown as mean ± s.d. from three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared to Scr control. d Representative images of the migration of scrambled, NatD-KD1, and NatD-KD2 cells in a time-lapse cell tracker migration assay from three independent experiments. Representative images of the migration (e) and invasion (f) of scramble, NatD-KD1, and NatD-KD2 cells with transwell assay from three independent experiments (top panel). Cell counts for the corresponding assays of at least four random microscope fields (x100 magnification). Cell migration and invasion are expressed as a percentage of control (bottom panel). Results are shown as mean ± s.d. from three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared to Scr control
false
- WB
CiteAb
Western blot - Anti-PATT1 antibody (AB106408)
Western Blotting using Anti-PATT1 antibody, ab106408. Publication image from Ju, J. et al., 2017, Nat Commun, 29030587. Legend direct from paper.
Nt-acetylation of histone H4 antagonizes phosphorylation of histone H4 serine 1 to regulate Slug expression. a Western blot analysis of indicated histone H4 modifications in Scr and NatD-KD H1299 cells. Histone H4 served as a loading control. b ChIP analysis of the enrichment of indicated histone H4 modifications on the Slug promoter in Scr and NatD-KD H1299 cells. IgG served as a negative control. Results are shown as mean ± s.d. from three independent experiments; two-tailed Student’s t-test, *P < 0.05, **P < 0.01 compared with the Scr control. c ChIP analysis of the enrichment of H3K4me3 and H3K27me3 on the Slug promoter in Scr and NatD-KD H1299 cells. IgG served as a negative control. Results are shown as mean ± s.d. from three independent experiments; two-tailed Student’s t-test, **P < 0.01 compared with the Scr control. d Western blot analysis of indicated proteins from H1299 cells overexpressing NatDδ or wild-type NatD. Histone H4 served as a loading control. e ChIP analysis of the enrichment of Nt-ac-H4 and H4S1ph on Slug promoter in H1299 cells overexpressing NatDδ or wild-type NatD. IgG served as a negative control. Results are shown as mean ± s.d. from three independent experiments; two-tailed Student’s t-test, *P < 0.05, **P < 0.01 compared with the wild-type control
false
- WB
CiteAb
Western blot - Anti-PATT1 antibody (AB106408)
Western Blotting using Anti-PATT1 antibody, ab106408. Publication image from Ju, J. et al., 2017, Nat Commun, 29030587. Legend direct from paper.
Silencing NatD suppresses cancer cell EMT by downregulating Slug. a Representative phase contrast images of Scr and NatD-KD H1299 cells treated with TGF-β1. Data are representative of three independent experiments. Scale bar, 100 µm. b Quantitative real-time PCR analysis of mRNA levels of indicated key EMT-related genes in Scr and NatD-KD H1299 cells normalized to GAPDH in the absence or presence of TGF-β1. Results are shown as mean ± s.d. of three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 or *P < 0.05 compared with the indicated control. c Western blot analysis of indicated protein levels in Scr and NatD-KD H1299 cells in the absence or presence of TGF-β1. GAPDH served as a loading control. Data are representative of three independent experiments. d Immunofluorescence analysis of Scr and NatD-KD H1299 cells in the absence or presence of TGF-β1 stained for E-cadherin and N-cadherin. Data are representative of three independent experiments. Scale bar, 20 µm. Migration (e, top) and invasion (f, top) of Scr cells, NatD-KD cells, and NatD-KD cells with enforced Slug expression (NatD-KD + Slug). (bottom panels) Cells were counted in at least four random microscope fields (x100 magnification) for the corresponding assays; migration and invasion are expressed as a percentage of control. Results are shown as mean ± s.d. of three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 compared with the indicated control. g Quantitative real-time PCR analysis of the mRNA levels of NatD and indicated key EMT-related genes (normalized to GAPDH) in Scr cells, NatD-KD cells, and NatD-KD + Slug cells. Results are shown as mean ± s.d. of three independent experiments. Two-tailed Student’s t-test was used. **P < 0.01 or *P < 0.05 compared with Scr or indicated control. h Western blot analysis of indicated protein levels in Scr cells, NatD-KD cells, and NatD-KD + Slug cells. GAPDH served as a loading control. Data are representative of three independent blots. i Pearson correlation scatter plot of the H score of Slug and NatD in human lung carcinoma (n = 147); r = 0.6672, P < 0.0001
false
反应性数据
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein supports vital processes related to peroxisome function and lipid metabolism. PATT1 associates with a transporter complex involved in importing long-chain fatty acids into peroxisomes. The protein ensures efficient breakdown and metabolism of lipids an important function for meeting cellular energy demands and integrity of cellular membranes. Disruptions in PATT1 activity may compromise fatty acid oxidation and broader metabolic homeostasis.
Pathways
The protein takes part in the peroxisomal beta-oxidation pathway and lipid metabolic pathways. This pathway involves important proteins such as ABCD2 and PMP70 which work alongside PATT1 to accomplish the efficient breakdown of fatty acids. These interactions highlight its role in maintaining energy balance within the cells linking to critical cellular energy production and metabolic processes.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
Epigenetics & chromatin 18:46 PubMed40665417
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 14: PubMed39334865
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:1187-1213 PubMed38383863
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 20:22 PubMed35057804
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 10:236 PubMed30858358
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:928 PubMed29030587
2017
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 9:e1003805 PubMed24068969
2013
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com